NITRICIL
"NITRICIL" is a word mark owned by Ligand Pharmaceuticals Incorporated, filed at the USPTO on October 12, 2026. It is under examination and covers class 1 (Chemicals).
- Status
- Under examination
- Since October 12, 2026
- Filed
- October 12, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50157034
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns NITRICIL
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ligand Pharmaceuticals Incorporated
LGND · Jupiter, United States
Representative
Gazal Pour-Moezzi
Sheppard Mullin Richter & Hampton LLP
What the mark covers
The products and services NITRICIL is filed for, grouped by Nice class.
nitric oxide releasing chemical compositions for use in the manufacture of pharmaceuticals
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Application filing receipt mailed
- New application entered
About NITRICIL
Who owns the trademark "NITRICIL"?
The USPTO trademark "NITRICIL" (application 50157034) is owned by Ligand Pharmaceuticals Incorporated.
What is the status of "NITRICIL"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull NITRICIL and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a137f0-a865-74e3-a50d-1bd69ca9699d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a137f0-a865-74e3-a50d-1bd69ca9699d",
"object": "trademark",
"mark_text": "NITRICIL",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50157034",
"filing_date": "2026-10-12",
"nice_classes": [
1
],
"owners": [
{
"name": "Ligand Pharmaceuticals Incorporated",
"entity_id": "ent_019f285f-a5a4-737a-ac5b-3007a0ca0bd4"
}
]
}